We are live on ! Find out more
BBNX

Beta Bionics
BBNX

116 hedge funds and large institutions have $659M invested in Beta Bionics in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 13

32% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 28

30% more capital invested

Capital invested by funds: $508M → $659M (+$151M)

14% more funds holding

Funds holding: 102 → 116 (+14)

7.25% more ownership

Funds ownership: 96.2% → 103.45% (+7.2%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
116
Holders Change
+14
Holders Change %
+13.73%
% of All Funds
1.53%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
28
Increased
37
Reduced
28
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$21.9M
2
DSCM
Divisadero Street Capital Management
Florida
+$13.4M
3
FCM
Farallon Capital Management
California
+$12.3M
4
VPC
Vestal Point Capital
New York
+$7.79M
5
Millennium Management
Millennium Management
New York
+$7.68M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$12.8M
2
BlackRock
BlackRock
New York
-$8.05M
3
PVI
Pura Vida Investments
New York
-$6.04M
4
Citadel Advisors
Citadel Advisors
Florida
-$5.75M
5
Holocene Advisors
Holocene Advisors
New York
-$4.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$4.56M +$97.9K +6,913 +2%
Goldman Sachs
27
Goldman Sachs
New York
$4.53M +$3.58M +252,579 +432%
ClearBridge Investments
28
ClearBridge Investments
New York
$3.64M -$1.69M -119,491 -32%
GGHC
29
Gilder Gagnon Howe & Co
New York
$3.56M +$3.46M +244,202 New
State Street
30
State Street
Massachusetts
$3.35M +$1.76M +124,023 +117%
Walleye Capital
31
Walleye Capital
New York
$3.18M +$992K +70,084 +47%
Raymond James Financial
32
Raymond James Financial
Florida
$3.15M +$3.06M +216,349 New
LP
33
Longaeva Partners
Illinois
$2.86M -$1.12M -79,218 -29%
AllianceBernstein
34
AllianceBernstein
Tennessee
$2.81M -$12.8M -903,938 -82%
FTM
35
First Turn Management
California
$2.29M +$2.23M +157,194 New
WP
36
Woodline Partners
California
$1.82M – – –
Charles Schwab
37
Charles Schwab
California
$1.49M +$8.65K +611 +0.6%
UBS Group
38
UBS Group
Switzerland
$1.4M -$400K -28,279 -23%
Northern Trust
39
Northern Trust
Illinois
$1.39M -$230K -16,234 -15%
Caisse de Depot et Placement du Quebec (CDPQ)
40
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$1.3M +$1.26M +89,105 New
Alyeska Investment Group
41
Alyeska Investment Group
Illinois
$1.09M – – –
Bank of America
42
Bank of America
North Carolina
$1.05M +$151K +10,687 +17%
SSA
43
Schonfeld Strategic Advisors
New York
$1.02M -$951K -67,147 -49%
BG
44
Bellevue Group
Switzerland
$973K – – –
Jennison Associates
45
Jennison Associates
New York
$862K -$119K -8,426 -12%
AQR Capital Management
46
AQR Capital Management
Connecticut
$807K +$785K +55,433 New
GCM
47
Ghisallo Capital Management
Massachusetts
$728K – – –
Verition Fund Management
48
Verition Fund Management
Connecticut
$662K +$258K +18,259 +67%
VFA
49
Values First Advisors
Tennessee
$620K +$70.5K +4,978 +13%
TD Asset Management
50
TD Asset Management
Ontario, Canada
$581K – – –
1
2
3 4 5

BBNX Hedge Fund Activity: Q2 2025 in Review

116 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Beta Bionics (BBNX) for Q2 2025, worth a combined $659M — up 30% from $508M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new BBNX positions and 13 closed out — a net gain of 15 holders — while 37 added to existing stakes and 28 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $21.9M. The largest seller was AllianceBernstein, cutting an estimated $12.8M.

  • 116 institutional investors held Beta Bionics (BBNX) as of Q2 2025, up from 102 in Q1 2025.
  • Funds reported $659M of Beta Bionics stock for Q2 2025, up 30% quarter-over-quarter.
  • 28 funds opened new Beta Bionics positions in Q2 2025 and 13 closed out, a net change of +15 holders.
  • The largest Beta Bionics buyer in Q2 2025 was Morgan Stanley, an estimated $21.9M added.
  • The largest Beta Bionics seller in Q2 2025 was AllianceBernstein, an estimated $12.8M sold.

Based on aggregated 13F filings for Q2 2025.